Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
ATRA:NASDAQ
Atara Biotherapeutics Inc
$5.01
+2.24%
(+0.11) 1D
Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATRA...
Open
$4.94
High
$5.11
Low
$4.80
Mkt. cap
40.97M
Avg. vol.
134.81K
Volume
26.58K
P/E ratio
1.95
52-wk high
$19.14
52-wk low
$3.92
EPS
$2.57
Beta
-0.34
Shares outstanding
8.18M
No. of employees
14
News stories
From sources across the web
About Atara Biotherapeutics Inc
CEO-
Employees14
Founded2012
HeadquartersThousand Oaks, California, United States
SectorBiotechnology
Last report
Mar 16, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.35/ (-0.06 est.)USD
-483.33%miss
Revenue / Estimate
1.60M/ (1.63M est.)USD
-2.35%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
98.15M
17.58M
3.45M
1.60M
Cost of goods sold
39.52M
554.00K
3.02M
783.00K
Cost of revenue
39.52M
554.00K
3.02M
783.00K
Research and development expenses
-
6.37M
-
2.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.01M
5.94M
3.98M
3.37M
Operating expense
10.01M
12.30M
3.98M
6.23M
Total operating expenses
49.53M
12.86M
7.00M
7.01M
Operating income
48.62M
4.72M
-3.55M
-5.42M
Other non operating income
-11.00K
22.00K
4.00K
-49.00K
EBT including unusual items
38.01M
2.39M
-4.28M
-3.41M
EBT excluding unusual items
47.82M
3.91M
-4.25M
-6.26M
Income tax expense
-
3.00K
28.00K
-
Effective tax rate
-
0.13%
-0.65%
-
Other operating expenses
-
-
-
-
Net income
38.01M
2.39M
-4.30M
-3.41M
Net profit margin
38.73%
13.58%
-124.62%
-213.54%
Earnings per share
3.50
0.19
-0.32
-0.35
Interest and investment income
236.00K
143.00K
204.00K
100.00K
Interest expense
-1.02M
-972.00K
-909.00K
-894.00K
Net interest expenses
-781.00K
-829.00K
-705.00K
-794.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
50.41M
5.62M
-3.19M
-4.37M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more